Anavex life sciences reports fiscal 2023 third quarter financial results

On track to release top-line data of potentially pivotal anavex®2-73-rs-003 phase 2/3 excellence pediatric clinical trial in the second half of 2023
AVXL Ratings Summary
AVXL Quant Ranking